Kantarci Feride Aylin, Faraji Ali Reza, Ozkul Aykut, Akata Fikret
Department of Ophthalmology, Fatih University Faculty of Medicine, Istanbul 34188, Turkey.
Department of Virology, Ankara University Faculty of Veterinary Medicine, Irfan Bastug Cad, Ankara 06110, Turkey.
Int J Ophthalmol. 2014 Aug 18;7(4):626-31. doi: 10.3980/j.issn.2222-3959.2014.04.07. eCollection 2014.
To investigate the permeability of amniotic membrane in herpes virus cell culture to acyclovir with real time polymerase chain reaction (RT-PCR).
Madin-Darby Bovine Kidney (MDBK) cell culture and Bovine Herpes Virus (BHV1) type 1 were used in the study. Cell cultures were grouped into two on the basis of herpes virus inoculation. Each group was sub-grouped into three. Amniotic membrane (V-HAM), acyclovir (V-A), and amniotic membrane and acyclovir (V-HAM-A) were applied to these subgroup cultures, respectively. After the application of the membrane and the drug, the cultures were evaluated at 24 and 48h for cytopathic effect positive (CPE+) with a tissue culture microscope. In the CPE (+) samples, the DNA was extracted for viral DNA analysis by RT-PCR.
In control cultures without herpes virus CPE was not detected. Besides, amniotic membrane and acyclovir did not have cytotoxic effect on cell cultures. CPE were detected in Bovine Herpesvirus type-1 inoculated cell cultures after amniotic membrane and/or acyclovir application. DNA analysis with RT-PCR indicated that Cycle threshold (Ct) values were lower in the BHV1 and membrane applied group (amniotic membrane group < acyclovir group < membrane and acyclovir group). This showed that membrane did not have antiviral effect. The membrane and acyclovir cell culture groups with high Ct values indicated that membrane was permeable and had a low barrier effect to drug.
In our in-vitro study, we found that amniotic membrane, which can be used in the treatment of corneal diseases, did not have antiviral effect. Besides, we detected that amniotic membrane was permeable to acyclovir in BHV-1 inoculated MDBK cell culture. However, more studies are necessary to investigate the quantitative effects of amniotic membrane and acyclovir.
通过实时聚合酶链反应(RT-PCR)研究羊膜在疱疹病毒细胞培养中对阿昔洛韦的通透性。
本研究采用马-达二氏牛肾(MDBK)细胞培养和1型牛疱疹病毒(BHV1)。细胞培养物根据疱疹病毒接种情况分为两组。每组再分为三个亚组。分别将羊膜(V-HAM)、阿昔洛韦(V-A)以及羊膜和阿昔洛韦(V-HAM-A)应用于这些亚组培养物。在应用羊膜和药物后,用组织培养显微镜在24小时和48小时评估培养物的细胞病变效应阳性(CPE+)情况。在CPE(+)样本中,提取DNA用于通过RT-PCR进行病毒DNA分析。
在无疱疹病毒的对照培养物中未检测到CPE。此外,羊膜和阿昔洛韦对细胞培养物无细胞毒性作用。在应用羊膜和/或阿昔洛韦后,在接种1型牛疱疹病毒的细胞培养物中检测到CPE。RT-PCR进行的DNA分析表明,在BHV1与羊膜应用组中(羊膜组<阿昔洛韦组<羊膜和阿昔洛韦组),循环阈值(Ct)值较低。这表明羊膜没有抗病毒作用。Ct值高的羊膜和阿昔洛韦细胞培养组表明羊膜具有通透性且对药物的屏障作用低。
在我们的体外研究中,我们发现可用于治疗角膜疾病的羊膜没有抗病毒作用。此外,我们检测到在接种BHV-1的MDBK细胞培养中羊膜对阿昔洛韦具有通透性。然而,需要更多研究来探讨羊膜和阿昔洛韦的定量作用。